$ cat ./records/gates-foundation-awards-800-000-to-uc-berkeley-to-develop-crispr--2021.txt
Gates Foundation awards $800,000 to UC Berkeley to develop CRISPR gene-editing tools for malaria mosquito control
[RECORD.TXT] · cat --full
The Gates Foundation awarded an $800,000 grant to the Marshall Laboratory at UC Berkeley School of Public Health to develop CRISPR-based genetic tools for malaria mosquito control. The research focuses on creating novel gene drive elements that can spread through wild Anopheles populations and reduce or eliminate their capacity to transmit malaria — operating as a complementary approach to existing insecticide-based methods. The Berkeley team's work spans both laboratory and computational modelling, assessing the ecological dynamics of gene drive spread across realistic mosquito population structures.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation and UNHCR upgraded fecal sludge treatment infrastructure in Cox's Bazar refugee camps serving 900,000 Rohingya
Next →
Gates Farmland Portfolio Spans Nebraska, Arizona, California, North Dakota, Wyoming, and More
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.